Relationship Between Vitamin D Biomarkers and Survival in Blood Samples From Patients With Advanced Pancreatic Cancer

NCT01327794 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 265

Last updated 2016-06-29

No results posted yet for this study

Summary

RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors identify and learn more about biomarkers related to cancer. It may also help doctors predict how well patients will respond to treatment.

PURPOSE: This research trial is studying the relationship between vitamin D biomarkers and survival in blood samples from patients with advanced pancreatic cancer.

Conditions

Interventions

GENETIC

polymorphism analysis

OTHER

immunologic technique

OTHER

laboratory biomarker analysis

OTHER

medical chart review

Sponsors & Collaborators

  • Alliance for Clinical Trials in Oncology

    lead OTHER
  • National Cancer Institute (NCI)

    collaborator NIH

Principal Investigators

  • Alan Venook, MD · University of California, San Francisco

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2014-08-31
Completion
2014-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01327794 on ClinicalTrials.gov